We prepared brain slices from mice with germinal deletion of CD44, hereafter CD44-/- (24), versus wild-type (WT) mice and implanted them with spheroids from different mouse or human glioma cell lines labelled with a fluorescent dye. This evidence concerns the gene CD44 and central nervous system cancer.